Project Details
Description
A Phase 2a, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of RVT-2401 in Myasthenia Gravis Patients
| Status | Finished |
|---|---|
| Effective start/end date | 1/1/19 → 12/31/21 |
Funding
- IMMUNOVANT, INC
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.